Sector consensus Merck & Co., Inc.

Equities

Market Closed - Nyse Other stock markets 20:00:02 10/03/2026 GMT			5-day change	1st Jan Change
117.09 ^USD	-0.02%		-2.29%	+11.24%

03-10	Merck's Winrevair Must Show Walk Distance Improvement to Build Confidence, RBC Says	MT
03-10	BioNTech founders plan exit to set up new venture, shares slump	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
MERCK & CO., INC.	US$127.22	+8.65%	27
ELI LILLY AND COMPANY	US$1,214.34	+21.27%	29
JOHNSON & JOHNSON	US$237.29	-2.63%	24
ABBVIE INC.	US$248.86	+9.63%	29
ROCHE HOLDING AG	CHF 364.79	+8.83%	19
NOVARTIS AG	CHF 151.21	-3.79%	21
ASTRAZENECA PLC	GBX 220	+11.57%	21
AMGEN INC.	US$350.04	-6.76%	28
GILEAD SCIENCES, INC.	US$156.59	+5.41%	27
NOVO NORDISK A/S	DKK 330.48	+33.82%	21
PFIZER INC.	US$28.43	+4.66%	26
BRISTOL-MYERS SQUIBB COMPANY	US$62.36	+3.71%	25
VERTEX PHARMACEUTICALS INCORPORATED	US$545.89	+9.36%	27
GSK PLC	GBX 20.32	-1.54%	20
SANOFI	€98.49	+29.06%	23
CHUGAI PHARMACEUTICAL CO., LTD.	JP¥9,823.33	+3.19%	15
TAKEDA PHARMACEUTICAL COMPANY LIMITED	JP¥5,536.87	-3.15%	15
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	CN¥82.39	+45.69%	17
HALEON PLC	GBX 4.266	+14.36%	16
ALNYLAM PHARMACEUTICALS, INC.	US$457	+41.76%	25
Average	1,003.01	+11.65%	23
Weighted average by Cap.	688.51	+9.79%	25